Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05048147 · ClinicalTrials.gov registry record · NA

Community Mobilization for Improved Clean Cookstove Uptake, Household Air Pollution Reduction, and Hypertension Prevention

A NA study of Hypertension, sponsored by NYU Langone Health.

Active
Registry status
NA
Development phase
1,280
Enrollment target
2
Study locations

NCT05048147: Active NA study of Hypertension, sponsored by NYU Langone Health.

NCT05048147 is a NA study of Hypertension that is active but no longer recruiting, run by NYU Langone Health. The registered enrollment target is 1,280 participants, below the 3,505-participant average among 470 other Hypertension trials with a reported enrollment target (63% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05048147, a NA study of Hypertension, is active but no longer recruiting, sponsored by NYU Langone Health.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
1,280 participants
Enrollment target
2
Study locations

Study Summary

Using a focused implementation research framework, the EPIS (Exploration, Preparation, Implementation and Sustainment) model in a type-2 hybrid design, the study will be conducted in 3 phases: 1) A pre-implementation phase that will use the Exploration and Preparation domains of EPIS to: a) explore barriers and facilitators of Clean Fuel- Clean- Stove (CF-CS) use, and b) develop a culturally-tailored CM strategy for CF-CS use; 2) An Implementation phase that will use the Implementation domain of EPIS to compare in a cluster RCT of 32 peri-urban communities (640 households), the effect of CM vs. a self-directed condition (i.e. receipt of information on CF-CS use without CM) on adoption of CF-CS use; and systolic BP reduction; 3) A post-implementation phase that will use the Sustainment domain of EPIS to evaluate the effect of CM strategy vs. self-directed condition on sustainability of the CF-CS use in 640 households across the randomly assigned 32 peri-urban communities in Nigeria. The Lagos State University College of Medicine (LASUCOM) working with the MOH will oversee research coordination in Nigeria.

Primary Outcome

Adoption defined as utilization of the CF-CS for more than 50% of cooking activities based on the metric developed by the Global Alliance for Clean Cookstoves. All traditional stoves and the bioethanol-based CF-CS in the participating households will be equipped with the iButtons SUMs to assess their use. Trained study staff will collect iButton temperature data during household visits.

Conditions Studied

Interventions

  • BEHAVIORAL Community Mobilization

Study Locations (2)

Illinois

  • University of Chicago - Chicago

New York

  • NYU Langone Health - New York

Trial Details

FieldValue
Enrollment Target 1,280 participants
Start Date 2023-04-11
Est. Completion 2026-06
Phase NA
NYU Langone Health

1,164 total trials

What the registry record for NCT05048147 still lists

NCT05048147 is an interventional study that assigns participants to a tested intervention. Its 1,280 participants enrollment target places it among the larger protocols in the corpus, below the 3,505-participant average among 470 other Hypertension trials with a reported enrollment target (63% lower).

The record links to 1 condition, with Hypertension appearing as the primary indexed condition, and to 1 intervention - of which Community Mobilization is the first listed.

NCT05048147 reports a single indexed study location in Illinois, New York.

Frequently Asked Questions

What is clinical trial NCT05048147 about?

NCT05048147 is a clinical study titled "Community Mobilization for Improved Clean Cookstove Uptake, Household Air Pollution Reduction, and Hypertension Prevention". Using a focused implementation research framework, the EPIS (Exploration, Preparation, Implementation and Sustainment) model in a type-2 hybrid design, the study will be conducted in 3 phases: 1) A pre-implementation phase that will use the Exploration and Preparation domains of EPIS to: a) explore ...

What is the current status of trial NCT05048147?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 1,280 participants. The study started on 2023-04-11. Estimated completion is 2026-06.

What conditions does trial NCT05048147 study?

This clinical trial studies the following conditions: Hypertension.

What interventions are being tested in trial NCT05048147?

The interventions under investigation include: Community Mobilization (BEHAVIORAL).

Who is sponsoring clinical trial NCT05048147?

This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05048147 being conducted?

This trial has 2 study locations across Illinois, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hypertension

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05048147's enrollment target sits among peer trials

1,280 54th of 470 higher than 417 of 470 other Hypertension trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Hypertension trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03970447 · 1,280 participants · Phase 2

    A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent Glioblastoma

  • NCT06468228 · 1,280 participants · Phase 3

    A Study to Assess Disease Activity and Safety of Lutikizumab in Adult and Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa

  • NCT07207811 · 1,280 participants · Phase 3

    CLEOPATTRA: A Research Study to Look at the Effects of Treatment With a Medicine Called Coramitug (NNC6019-0001) in People With Heart Failure Due to Transthyretin Amyloid (ATTR) Amyloidosis

  • NCT06626022 · 1,284 participants · Phase 3

    Screening for Prostate Cancer Using High Resolution Micro-ultrasound Versus Multiparametric Magnetic Resonance Imaging.

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05048147, the US trial registry maintained by the National Library of Medicine. NCT05048147 (large enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.